However, I think there's one stock you can buy in October that could have nothing but blue skies ahead: Biotech veteran Vertex Pharmaceuticals (NASDAQ: VRTX). It's true that the company's cash flows and bottom-line profits haven't recovered from the drastic haircuts of the coronavirus lockdown era, but even amid an economic crisis tinged with inflation, sales are reaching record highs. Iger will hold the reins in his capable hands at least until 2026, rebuilding the damaged brand and finding the right balance between digital streaming and traditional content publishing.